AT382381B - Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate - Google Patents

Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate

Info

Publication number
AT382381B
AT382381B AT312184A AT312184A AT382381B AT 382381 B AT382381 B AT 382381B AT 312184 A AT312184 A AT 312184A AT 312184 A AT312184 A AT 312184A AT 382381 B AT382381 B AT 382381B
Authority
AT
Austria
Prior art keywords
new interface
producing new
carbohydrate derivatives
interface characteristic
characteristic carbohydrate
Prior art date
Application number
AT312184A
Other languages
English (en)
Other versions
ATA312184A (de
Inventor
Gerd Dr Greber
Heinrich Dr Gruber
Original Assignee
Oesterr Zuckerfab Evidenz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oesterr Zuckerfab Evidenz filed Critical Oesterr Zuckerfab Evidenz
Priority to AT312184A priority Critical patent/AT382381B/de
Priority to EP19850904581 priority patent/EP0197053A1/de
Priority to PCT/AT1985/000036 priority patent/WO1986002076A1/de
Publication of ATA312184A publication Critical patent/ATA312184A/de
Application granted granted Critical
Publication of AT382381B publication Critical patent/AT382381B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/08—Ethers
    • C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • C08B31/125—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch having a substituent containing at least one nitrogen atom, e.g. cationic starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT312184A 1984-10-02 1984-10-02 Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate AT382381B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT312184A AT382381B (de) 1984-10-02 1984-10-02 Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
EP19850904581 EP0197053A1 (de) 1984-10-02 1985-10-01 Grenzflächenaktive kohlenhydrat-derivate und verfahren zu deren herstellung
PCT/AT1985/000036 WO1986002076A1 (fr) 1984-10-02 1985-10-01 Derives d'hydrates de carbone tensioactif et procede pour leur preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT312184A AT382381B (de) 1984-10-02 1984-10-02 Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate

Publications (2)

Publication Number Publication Date
ATA312184A ATA312184A (de) 1986-07-15
AT382381B true AT382381B (de) 1987-02-25

Family

ID=3545630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT312184A AT382381B (de) 1984-10-02 1984-10-02 Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate

Country Status (3)

Country Link
EP (1) EP0197053A1 (de)
AT (1) AT382381B (de)
WO (1) WO1986002076A1 (de)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390788B2 (en) 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
EP2158920A1 (de) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren
WO2010075465A1 (en) 2008-12-22 2010-07-01 Aegis Therapeutics, Llc Compositions for drug administration
WO2011036521A2 (en) 2009-09-25 2011-03-31 Dr. Reddy's Laboratories Limited Formulations comprising triptan compounds
EP2457580A1 (de) 2004-08-25 2012-05-30 The UAB Research Foundation Absorptionsverbesserer zur Arzneimittelverabreichung
WO2012158962A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2015184177A1 (en) 2014-05-28 2015-12-03 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
EP3434696A1 (de) 2012-11-20 2019-01-30 Mederis Diabetes, LLC Verbesserte peptidarzneimittel für insulinresistenz
EP3444281A1 (de) 2012-11-20 2019-02-20 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
WO2019193204A1 (en) 2018-04-06 2019-10-10 Cyprumed Gmbh Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
WO2020049523A1 (en) 2018-09-07 2020-03-12 Upsher-Smith Laboratories, Llc Methods of treating migraine
WO2022049310A1 (en) 2020-09-07 2022-03-10 Cyprumed Gmbh Improved pharmaceutical formulations of glp-1 receptor agonists
US11541028B2 (en) 2018-01-03 2023-01-03 Altimmune Inc. Peptide pharmaceuticals for treatment of NASH and other disorders
WO2023166179A1 (en) 2022-03-03 2023-09-07 Cyprumed Gmbh Improved oral pharmaceutical formulations of therapeutic peptides and proteins

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4413686C2 (de) * 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
US5627273A (en) * 1995-01-31 1997-05-06 National Starch And Chemical Investment Holding Corporation Method for preparing hydrophobically-terminated polysaccharide polymers and detergent compositions comprising the polysaccharide polymers
KR20070100879A (ko) * 2004-10-15 2007-10-12 대니스코 에이/에스 발포 이소시아네이트계 중합체, 이를 제조하기 위한 믹스및 이의 제조방법
US7465757B2 (en) 2004-10-15 2008-12-16 Danisco A/S Foamed isocyanate-based polymer, a mix and process for production thereof
WO2006040335A1 (en) * 2004-10-15 2006-04-20 Danisco A/S A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096292A1 (de) * 1982-05-29 1983-12-21 BEHRINGWERKE Aktiengesellschaft Beta-D-Galactosederivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR903547A (fr) * 1943-04-08 1945-10-08 Ste Ind Chim Bale Nouveaux composés amidiques
AT360046B (de) * 1979-04-12 1980-12-10 Oesterr Zuckerfab Evidenz Verfahren zur herstellung von neuen kohlen- hydrat-derivaten
AT369383B (de) * 1981-06-12 1982-12-27 Oesterr Zuckerfab Evidenz Verfahren zur herstellung von beta-amidoethyl -ether-derivaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096292A1 (de) * 1982-05-29 1983-12-21 BEHRINGWERKE Aktiengesellschaft Beta-D-Galactosederivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2457580A1 (de) 2004-08-25 2012-05-30 The UAB Research Foundation Absorptionsverbesserer zur Arzneimittelverabreichung
US7390788B2 (en) 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
EP2158920A1 (de) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren
EP2158898A1 (de) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
EP2505189A1 (de) 2006-06-23 2012-10-03 Aegis Therapeutics, LLC Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
WO2010075465A1 (en) 2008-12-22 2010-07-01 Aegis Therapeutics, Llc Compositions for drug administration
WO2011036521A2 (en) 2009-09-25 2011-03-31 Dr. Reddy's Laboratories Limited Formulations comprising triptan compounds
WO2012158962A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
EP4286400A2 (de) 2011-05-18 2023-12-06 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
EP3566711A1 (de) 2011-05-18 2019-11-13 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
EP3434696A1 (de) 2012-11-20 2019-01-30 Mederis Diabetes, LLC Verbesserte peptidarzneimittel für insulinresistenz
EP3444281A1 (de) 2012-11-20 2019-02-20 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
EP3653649A1 (de) 2012-11-20 2020-05-20 Mederis Diabetes, LLC Verbesserte peptidarzneimittel für insulinresistenz
EP4047023A1 (de) 2012-11-20 2022-08-24 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
WO2015184177A1 (en) 2014-05-28 2015-12-03 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
EP4397374A2 (de) 2014-05-28 2024-07-10 Mederis Diabetes, LLC Verbesserte peptidarzneimittel für insulinresistenz
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
US11541028B2 (en) 2018-01-03 2023-01-03 Altimmune Inc. Peptide pharmaceuticals for treatment of NASH and other disorders
WO2019193204A1 (en) 2018-04-06 2019-10-10 Cyprumed Gmbh Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
WO2020049523A1 (en) 2018-09-07 2020-03-12 Upsher-Smith Laboratories, Llc Methods of treating migraine
WO2022049310A1 (en) 2020-09-07 2022-03-10 Cyprumed Gmbh Improved pharmaceutical formulations of glp-1 receptor agonists
WO2023166179A1 (en) 2022-03-03 2023-09-07 Cyprumed Gmbh Improved oral pharmaceutical formulations of therapeutic peptides and proteins

Also Published As

Publication number Publication date
WO1986002076A1 (fr) 1986-04-10
ATA312184A (de) 1986-07-15
EP0197053A1 (de) 1986-10-15

Similar Documents

Publication Publication Date Title
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
AT382381B (de) Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
AT386208B (de) Verfahren zur herstellung neuer carbapenemzwischenverbindungen
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA233086A (de) Verfahren zur herstellung neuer peptidantibiotika
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
AT387015B (de) Verfahren zur herstellung neuer acylaminophenolderivate
ATA260285A (de) Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate
AT387576B (de) Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate
AT381097B (de) Verfahren zur herstellung neuer thiazolintriazinderivate
ATA143885A (de) Verfahren zur herstellung neuer chinolinderivate
ATA86285A (de) Verfahren zur herstellung neuer thiazolderivate
AT388557B (de) Verfahren zur herstellung neuer bornanderivate
AT383118B (de) Verfahren zur herstellung neuer azetidinonderivate
ATA151286A (de) Verfahren zur herstellung neuer benzthiazolderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee